Initial and Serial Evaluation of the HF Patient

Revision as of 21:30, 9 August 2013 by Mahmoud Sakr (talk | contribs) (Created page with " |- | bgcolor="LightGreen"|<nowiki>"</nowiki>'''.''' Repeat measurement of EF and measurement of the severity of structural remodeling are useful to provide information in pat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

|- | bgcolor="LightGreen"|". Repeat measurement of EF and measurement of the severity of structural remodeling are useful to provide information in patients with HF who have had a significant change in clinical status; who have experienced or recovered from a clinical event; or who have received treatment, including GDMT, that might have had a significant effect on cardiac function; or who may be candidates for device therapy. (Level of Evidence: C) "

Retrieved from "https://www.wikidoc.org/index.php?title=Initial_and_Serial_Evaluation_of_the_HF_Patient&oldid=892072"